ZA893101B - Certain paf antagonist/antihistamine combinations and methods - Google Patents

Certain paf antagonist/antihistamine combinations and methods

Info

Publication number
ZA893101B
ZA893101B ZA893101A ZA893101A ZA893101B ZA 893101 B ZA893101 B ZA 893101B ZA 893101 A ZA893101 A ZA 893101A ZA 893101 A ZA893101 A ZA 893101A ZA 893101 B ZA893101 B ZA 893101B
Authority
ZA
South Africa
Prior art keywords
methods
certain
paf antagonist
combinations
antihistamine
Prior art date
Application number
ZA893101A
Other languages
English (en)
Inventor
M Motasim Billah
Motasim Billah M
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA893101B publication Critical patent/ZA893101B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA893101A 1988-04-27 1989-04-26 Certain paf antagonist/antihistamine combinations and methods ZA893101B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27

Publications (1)

Publication Number Publication Date
ZA893101B true ZA893101B (en) 1989-12-27

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893101A ZA893101B (en) 1988-04-27 1989-04-26 Certain paf antagonist/antihistamine combinations and methods

Country Status (15)

Country Link
EP (2) EP0402422A1 (es)
JP (1) JPH0655673B2 (es)
KR (1) KR930009786B1 (es)
AT (1) ATE84724T1 (es)
AU (1) AU619555B2 (es)
CA (1) CA1327316C (es)
DE (1) DE68904475T2 (es)
DK (1) DK255190D0 (es)
ES (1) ES2044100T4 (es)
IE (1) IE63697B1 (es)
IL (1) IL90100A (es)
MY (1) MY106956A (es)
NZ (1) NZ228879A (es)
WO (1) WO1989010143A1 (es)
ZA (1) ZA893101B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
ATE128030T1 (de) * 1990-08-02 1995-10-15 Hoffmann La Roche Antiallergische mischung.
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
DK255190A (da) 1990-10-23
EP0345931A1 (en) 1989-12-13
IL90100A0 (en) 1989-12-15
AU3578289A (en) 1989-11-24
DE68904475D1 (de) 1993-03-04
KR900700136A (ko) 1990-08-11
ATE84724T1 (de) 1993-02-15
CA1327316C (en) 1994-03-01
AU619555B2 (en) 1992-01-30
MY106956A (en) 1995-08-30
DK255190D0 (da) 1990-10-23
ES2044100T4 (es) 1996-07-16
ES2044100T3 (es) 1994-01-01
JPH03502097A (ja) 1991-05-16
IE63697B1 (en) 1995-05-31
NZ228879A (en) 1992-08-26
IL90100A (en) 1995-01-24
DE68904475T2 (de) 1993-05-13
JPH0655673B2 (ja) 1994-07-27
WO1989010143A1 (en) 1989-11-02
EP0402422A1 (en) 1990-12-19
IE891362L (en) 1989-10-27
EP0345931B1 (en) 1993-01-20
KR930009786B1 (ko) 1993-10-11

Similar Documents

Publication Publication Date Title
DE68920529T2 (de) Blockcopolymere und Zusammensetzungen davon.
DE3853340T2 (de) Dien-Blockpolymer und Polymerzusammensetzung.
IE831613L (en) Heterocyclyl piperidine compounds
DE69022567T2 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
ATE253352T1 (de) Verwendung einer zusammensetzung enthaltend polyether block copolymere
DE68912237T2 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE69009822D1 (de) Zusammensetzung und ihre Verwendung.
DE68906345T2 (de) Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
DE384953T1 (de) Huepfspiel und dessen spielart.
IL90100A0 (en) Certain paf antagonist/antihistamine combinations and methods
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AU3262389A (en) Set or game for the composition of figures, shapes and patterns
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
DE3867400D1 (de) Copolymere, verwendbar als multifunktioneller zusatz in schmiermitteln und diesen enthaltende zusammensetzungen.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE68910057D1 (de) Behandlungszusammensetzungen.
DE58902310D1 (de) Tetrahydropyridin-derivate.
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물